Octant Bio
Biotechnology company developing small-molecule medicines for patients with genetic and other serious diseases
Highlights
- New on EvolcAdded 2026-11-13
Recent signals
What changed at Octant Bio in the last 6 months, newest first. Each line links to its public source.
- 27 Oct 2026 In the news · Octant Bio receives FDA orphan drug designation for OCT-980 octant.bio
About Octant Bio
Octant engineers human cells to study disease biology and screens large libraries of molecules to guide drug discovery using its Navigator platform, which combines biology, chemistry, machine learning and automation. Its pipeline includes programs for genetic disease, cancer and metabolism, including OCT-980 for rhodopsin-associated retinitis pigmentosa.
The company develops therapeutics and collaborates on drug discovery; named collaborators include Bristol Myers Squibb and the Gates Foundation. It is hiring for roles in biology, chemistry, compute, platform operations and finance in Emeryville, California.
Product: Small-molecule therapeutics and a drug-discovery platform that combines engineered-cell assays, chemistry, machine learning and automation.
Jobs at Octant Bio
More biotech & pharma companies
Olema Oncology
Clinical-stage biopharmaceutical developing novel therapies for patients with metastatic breast canceronepot
Automated custom small-molecule synthesis for researchers and organizations developing chemical compoundsYoung companyNew on EvolcOssium Health
Bone marrow-derived cell therapies for healthcare providers and life science companiesNew on EvolcOxfordbiotherapeutics
Develops antibody-based cancer therapies and target-discovery services for oncology partners and patientsRemote-friendlySalary transparentParabilis Medicines
Develops peptide-based medicines for patients with serious diseases, including cancerSalary transparentParallel Bio
Human-first drug discovery platform for pharmaceutical and biotechnology companiesSalary transparent
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Analytics 4High confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- HotjarMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinitialization/configuration expression
- Integration code on pageinitialization/configuration expression
- Integration code on pageinitialization/configuration expression
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Content management
- WebflowHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- Website resourcedeclared script/iframe or software asset
Hosting
- AWSHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.